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In recent years BordetelIa  perlussis  (or soluble products obtained from fluid 
cultures of this organism) has been shown to have potent biological activity in 
mice and rats. Thus, pertussis-treated animals exhibit the following : (a) marked 
leukocytosis (1, 2) ; (b) an increase in sensitivity to the lethal effects of histamine, 
acetylcholine,  serotonin,  bradykinin,  endotoxin,  and  a  variety of nonspecific 
stimuli such as cold stress  (3);  (c)  potentiation of the  immune response with 
selective stimulation  of homocytotropic antibody  synthesis  (4,  5);  (d)  a  de- 
creased physiological and  metabolic response  to  the  intravenous  injection  of 
epinephrine (5, 6). The reduction in epinephrine responsiveness has been inter- 
preted as being due  to/3 adrenergic blockade, and has led to speculation  that 
alterations in adrenergic responsiveness might underlie other biological effects 
of the organism (5). 
Since adrenergic agents exert their effects on cells by producing changes in 
intracellular  cyclic AMP  concentrations,  it  would  be  desirable  to  study  the 
effect of pertussis on cyclic AMP metabolism, preferably in  a  wholly in vitro 
system so that the complexities of in vivo metabolic studies could be avoided. 
A suitable tissue for these studies would be lymphocytes, since the ability of cells 
in  the  recirculating  lymphocyte pool to emigrate from the blood is markedly 
decreased in pertussis-treated animals, which suggests a  change in the surface 
properties  of  these  cells  (7).  In  the  present  report,  evidence  indicating  that 
B. pertussis is able to alter cyclic AMP metabolism in human lymphocytes is 
presented. 
Materials and Methods 
Preparation of B. perPussis Culture Supernatant Fluid Fractions.--B. pertussis strain  NIH 
114  (3779B) was cultured in the  medium and under the  conditions described previously, 
except that the anion exchange resin was not utilized (2). After the addition of thimerosal to a 
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final concentration of 1:5,000,  the bacterial cells were removed by centrifugation. Fractiona- 
tion of the culture supernatant fluids  was achieved by the successive use of  (NH4)2SO4, 
density gradient centrifugation, and gel filtration on Sephadex G-150 (Pharmacia Fine Chemi- 
cals,  Inc., Piscataway, N.  J.). A typical scheme of fractionation and the designation of the 
products are summarized in Fig. 1. 
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FIG.  1.  Representative scheme for the preparation of fractions from B. pertussls culture 
supernatant fluids.  Tris-NaC1  is 0.1  M  Tris-0.5  M  NaC1, pH 10.0. 
All fractions were dissolved in, or dialyzed against, 0.1 M Tris-0.5  M NaCI, pH 10  (Tris- 
NaC1), and diluted in the same buffer.  The dilutions represent equivalent dilutions in terms 
of the volume of the original culture supernatant fluid. Thus, a fraction diluted 1 : 100 would 
contain in 1 ml an amount present in 0.01 ml of the culture supernatant fluid,  assuming no 
loss. Alternatively, samples of the fractions were dialyzed exhaustively against distilled water, 
dried from the frozen state, and weighed. 1080  B.  PERT USSIS  AND  CYCLIC AMP 
Leukocytosis.--0.2 ml of dilutions of the fractions were injected intravenously into adult 
female Albany strain mice. Leukocyte counts were obtained 3 clays later, utilizing a Model B 
Coulter Counter  (Coulter Electronics, Inc., Fine Particle Group,  Hialeah, Fla.). 
Histamine Sensitivity.  After samples of blood  for leukocyte counts had been obtained,  1 
mg of histamine dichloride contained in 0.5 ml of isotonic saline was injected intraperitoneally 
Deaths generally occurred within a few horn s, but a 24-h period was used for scotlng. 
Lymphocyte  Purificallon.--Heparinized  peripheral  blood  was  obtained  from  normal, 
healthy, human volunteers. Dextran  (clinical grade H, Pharmachem Corp., Bethlehem, Pa.) 
was added  to a  final concentration  of 0.6~,  and  the cells were separated  by gravity sedi- 
mentation at 37°C for 45-60 min. Cells in the leukocyte-rich supernatant  were washed with 
0.15  M  NaC1-0.01  M  PO4, pH 7.4  (PBS), t and then passed  through nylon  columns  as de- 
scribed previously (8). The nonadherent  cells were centrifuged twice at  100 g for 7 min and 
washed twice with PBS to remove platelets. The purified cell preparations contained  >98% 
lymphocytes  (200  nucleated  cells  counted).  Lymphocyte recovery averaged  approximately 
25%. 
Cell Incubation Experiments.--Sources  and  methods  for  preparing  solutions of  catechol- 
amines  and  prostaglandins  have been  described previously. Methacholine (acetyl-#-methyl- 
choline,  Aldrich Chemical Co.,  Inc.,  Milwaukee,  Wis.)  and  acetylcholine  (Sigma  Chemical 
Co., St.  Louis,  Mo.)  were dissolved in 0.15  M  NaC1 just  before use.  Purifed  lymphocytes 
were suspended in Gey's solution at concentrations of 1 5 X  106 cells/ml. Incubation volumes 
of 0.5 or 1.0 ml/tube were used. In the usual experiment, cells were preincuhated with pertussis 
fractions for various time periods at 0 or 37°C, and 0.1 vol of PBS or PBS containing isopro- 
terenol, prostaglandin E1 (PGE1),  or a cholinergic agent was then added. After an  additional 
10 or 15 rain at 37°C, the tubes were centrifuged at 2,500 rpm for 2 min at room temperature, 
the supernatants  were decanted,  and  the cell pellets were frozen in ethanol-dry ice.  Samples 
were stored at  -70°C until assay. Cyclic AMP was determined by radioimmunoassay.  Data 
on the specificity and sensitivity of the immunoassay have heen presented in detail previously 
(8,  9). 
RESULTS 
Inhibilion of Isoprolerenol Responses by Crude Perlussis Cullure Fluid.--Puri- 
fled lymphocytes were incubated  at 37°C with dialyzed crude pertussis  culture 
supernatant  (fraction  [Fx]  1, see Fig.  1)  for various time periods and then stim- 
ulated  with  1 and  10  mM  isoproterenol  (Fig.  2).  Preincubation  of cells for 90 
rain in the presence of a  1 : 100 dilution of fraction  1 resulted in complete inhibi- 
tion  of  the  cyclic AMP  response  to  1  mM  isoproterenol  and  nearly  complete 
inhibition of the  10 mM  isoproterenol response. At the lower isoproterenol con- 
centration,  partial  inhibition  was  also  observed  after  preincubation  with  the 
1:10,000  dilution.  When  the  preincubation  period  was  shortened  to  20  rain, 
little or no inhibition was observed, even at the highest fraction 1 concentration. 
On the basis of these observations a preincubation period of 90 min at 37°C was 
selected  as  a  suitable  condition  for further  studies. 
Inhibition  of lsoprolerenol Responses by Perlussis Fraclions.--In  an  effort to 
characterize  the  isoproterenol-inhibiting  activity further,  partially  purified  B. 
perlussis culture fractions  (see  Fig.  1)  were evaluated.  Table i  summarizes  the 
l Abbrevialions used in this paper: Fx, fraction; PBS,  phosphate-buffered  saline  (0.15  M 
NaCI-0.01  M  POl, pH 7.4) ; PGEi, prostaglandin E~ ; PHA, phytohemagglutinin. CHARLES  W.  PARKER  AND  STEPHEN  I,  MORSE  1081 
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FIG. 2. Lymphocytes were preincubated for 20 and 90 min at 37°C with various dilutions of 
dialyzed  culture  supernatant  fluid  (fraction  1)  or  buffer.  Isoproterenol or  buffer was  then 
added, and cellular cyclic AMP was measured after an additional 10 rain at 37°C. 
histamine- and leukocytosis-stinmlating activities of these fractions. Leukocy- 
tosis was stimulated most effectively by fraction 4. Fractions 3 and 5 also had 
significant activity, particularly the former, whereas fraction 2 was essentially 
inactive.  Considerable histamine-sensitizing activity was present  in fractions 
3, 4, and 5, fraction 4 again being the most potent. 
The effect of the various fractions on the lymphocyte isoproterenol response 
is shown in Fig. 3. In comparison with the dialyzed supernatant  (fraction 1), 
fraction 2 was  almost completely inactive as an inhibitor of the cyclic AMP 
response to /3 adrenergic stimulation, whereas striking inhibitory activity was 
present in fractions 3 and 4, correlating well with the leukocytosis-producing 
activity of these fractions. This raises the possibility that leukocytosis induction 
and catecholamine inhibition have a common basis. However, it is necessary to 
explain why the total inhibitory activity in fractions 3 and 4 was actually greater 
than  that  in fraction  1  (e.g.,  there was  >  100%  recovery of activity during 
purification). 
This discrepancy may be due to the instability of the crude extract, which 
loses its leukocytosis-stimulating activity more readily than fractions 3 and 4. 
The cyclic AMP experiments were performed 5 days or more after the injection 
of animals for determination of leukocytosis-producing activity, and significant 
decay in fraction 1 activity might have occurred during this period. Alterna- 
tively, it may be that maximal activity was present, which  could not be in- 
creased by the presence of more of the inhibitor; such a phenomenon has been 
described for the leukocytosis-promoting factor. An example is seen in Table I 
tor fractions 3 and 4C. Similar explanations might account for the greater in- 1082  B.  PERTUSSIS  AND  CYCLIC  AMP 
TABLE  I 
Representative Leukocylosis and Histamine-Sensitizing 
A ctlvilies of Various B. pertussis Fractions 
Fraction  Weight injected  Leukocyte count*  Histamine+  + 
4A 
#g  mm~  X  10  a 
5  96.3  3/4 
1  48.6  1/4 
0.2  25.1  0/4 
10  33.4  1/4 
2  17.0  0,.'4 
5  87.6  4/4 
1  108.9  1/'4 
0.2  71.6  1/'4 
1  135.8  3/4 
0.2  90.0  3,.'3 
5  46.8  0/4 
1  23.7  0/4 
4C  1  108.1  2/4 
0.2  94.6  0/'4 
5  100.0  4/4 
1  48.2  2/4 
0.2  27.1  0/4 
* The leukocyte counts were determined 3 days after injection. 
These same mice were injected intraperitoneally with  1 mg of histamine dihydrochlo- 
ride after the leukocyte counts were done. The results are expressed as number dead/'total 
number. 
hibitory activity in fractions 4  and 5  (taken  together)  than  in fraction 3,  from 
which fractions 4  and 5 are derived. 
Ej~ect  of tYrlussis  Fractions  on PGEt and Cholinergic  Stimulalion.--Having 
established that pertussis culture fractions inhibit the cyclic AMP  response to 
isoproterenol, it seemed desirable to evaluate the effect of other agents (PGE1, 
cholinergic agents)  that  raise lymphocyte  cyclic AMP  concentrations.  When 
PGE1  was  used  to  stimulate lymphocytes  that  had  been  exposed  to  various 
pertussis fractions, the same fractions that inhibited isoproterenol responsive- 
hess  reduced  the  PGE1  response  (Fig. 4).  The  response  to  cholinergic agents 
also was inhibited (see below). Thus, the inhibition of the cyclic AMP response 
by pertussis involves nonadrenergic as well as adrenergic stimuli. 
Experiments  with  Known  Quantities  of Perlussis  Fraction  4.--Inhibition of 
the cyclic AMP response by fraction 4 is considered in more detail in Table II. CHARLES  W.  PARKER  AND  STEPHEN  I.  MORSE  1083 
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FIG. 3. 1.2 X  106 lymphocytes were preincubated with the indicated dilutions of B. pertussis 
fractions 1  5 for 90 min at 37°C, after which isoproterenol was added to a final concentration 
of 10 mM and the incubation continued for  another  10 rain. In control tubes  10 mM  isopro- 
terenol  incteased  the cyclic AMP  concentration from  20.8  to  124 pmol/107  cells.  Fraction 
dilutions are expressed on the basis of the amount of dialyzed crude culture fluid supernatant 
(fraction 1) used as starting material. Thus 1 ml of fraction 4, undiluted,  was obtained from 1 
ml  of  fraction  1.  With  this  particular  culture  preparation,  the  average  mouse  leukocyte 
responses  (evaluated  after 72 h)  to 0.4 ml of fractions 2, 3, 4,  and 5 were 51,  211,  191,  and 
131  X  10a/ram 3,  respectively;  0.2  ml  of  the parent  fraction  1 produced  a  leukocytosis  of 
237  X  lOa/mm a. 
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FIO. 4.  1.2  X  106 lymphocytes were preincubated with the indicated concentrations of  B 
pertussls fractions 1-5 for 90 rain at 37°C, after which PGEI was added to a final concentration 
of 120 nM and the incubation continued for another 10 rain. In control tubes PGE1  increased 
the concentration of cyclic AMP from 20.8 to 48 pmol/107 cells. For an explanation of fraction 
dilutions,  see legend for Fig. 3. 
Responses to 0.1, 1.0, and 10 mM isoproterenol, 30 and 3 #M PGE,, and 3 mM 
methacholine were all markedly inhibited at 500 ng/ml concentrations of frac- 
tion 4. The 30/~M PGEI and 1.0 mM isoproterenol cyclic AMP responses were 
also evaluated at fraction 4 concentrations of 50 and 5 ng/ml; 48 % or more in- 
hibition was obtained  in  each instance.  Thus concentrations  of fraction 4  as 108:1:  B.  PERTUSSIS  AND  CYCLIC  AMP 
TABLE  II 
Esffecl o/" Fraction 4 on lke Cyclic AMP Response of tluman Lymphocytes* 
Fraction 4 concentrat!on  Cyclic AMP/10  7 cells  Inhibition 
ng/~  l  pmol  c5  4, 
Buffer  --  9.0 
Buffer  500  13.0 
10.0 mM isoproterenol  --  128.0 
10.0 mM isoproterenol  500  14.0  96 
1.0 mM isoproterenol  -  30.0 
1.0 mM isoproterenol  500  18.0  57 
1.0 mM isoproterenol  50  14.0  84 
1.0 mM isoproterenol  5  18.0  70 
0.1 mM isoproterenol  35.0 
0.1 mM isoproterenol  500  15.0  73 
30/~M PGE,  --  112.0 
30 #M PGE1  500  43.0  65 
30 #M PGE~  50  46.0  64 
30 #M PGE1  5  63.0  48 
3 #M PGE1  --  120.0 
3 #M PGE1  500  33.0  78 
3 n~M methacholine  15.0 
3 mbl methacholine  500  9.0  100 
* 1.6 X  106 lymphocytes in a  volume of 1.0 ml were preiucubated with the indicated con- 
centrations of fraction 4 for 90 min at 37°C,  after which isoproterenol, PGE1,  methacholine, 
or buffer  was added and the incubation continued for another 10 min at 37°C.  Percent inhi- 
bition is based on a buffer control cell concentration of 9 pmol cyclic AMP/'10 ~ cells. 
low as 5  ng/ml  (3.1  ng/106  lymphocytes)  inhibited  the  cyclic AMP  response, 
and  the possibility that  inhibitory effects might occur at  still lower concentra- 
tions was not excluded. 
Further Characterization  of the Activity in Fraction 4.--In  an  effort to  better 
characterize  the inhibitory  activity in fraction 4,  the fraction was subjected to 
Sephadex  G-150  chromatography.  Fraction  4A,  which  was  excluded  from  the 
gel,  did  not  produce  marked  leukocytosis  and  had  little  or  no  effect  on  the 
lymphocyte  cyclic AMP  response.  Inhibition  of the  cyclic AMP  response  was 
obtained  with fraction 4C,  which  was  eluted just  behind  the  exclusion volume 
(Table III). This fraction also contained the bulk of the leukocytosis-producing 
activity. However, in comparing fraction 4C with the parent fraction 4, recov- 
ery of leukocytosis-producing activity appeared  to be greater than  the recovery 
of cyclic AMP  inhibitory activity. 
Effect  of i°reincubation  Temperalure.--In  view  of  the  delayed  onset  of  the 
inhibition of cyclic AMP  responsiveness in time experiments, it seemed desirable CHARLES  W.  PARKER  AND  STEPHEN  I.  MORSE  1085 
to  evaluate the effect of preincubation  temperature.  When  cells were  preincu- 
bated  with active pertussis fractions at 0°C  for 90 rain,  there was  little or  no 
impairment  of isoproterenol responsiveness.  (A representative experiment with 
fraction 4  is shown in Table IV.)  Thus  there was  temperature  as well as time 
dependency  for the inactivation. 
Washing Experimenls.--In  a  single experiment, cells were preincubated with 
TABLE  III 
Effect of Fraction 4 and Its Sub  fractions (4A and 4C) 
on the Lymphocyte Cyclic AMP Response to PGEt* 
Fraction  Cyclic AMP  Inhibition 
~mol/107 cells  % 
Buffer  10 
PGE1 3 #M  25 
PGE1 3/~M  4,  1 : 100  13  80 
PGE~ 3/~M  4, 1 : 1,000  9  100 
PGE1 3/~M  4,  1 : 10,000  11  94 
PGE~ 3 #M  4,  1 : 100,000  26  0 
PGEt 3 ~zM  4C,  1 : 100  13  80 
PGEL 3 /zM  4C,  1 : 1,000  23  13 
PGE~ 3/zM  4C,  1 : 10,000  27  0 
PGEt 3/zM  4A, 1 : 100  27  0 
PGE~ 3 #M  4A, 1 : 1,000  25  0 
PGE~ 3/zM  4A, 1 : 10,000  25  0 
* For incubation conditions and explanation of percent inhibition, see legend to "Fable lI. 
TABLE  IV 
l({fect  of Preincubation Temperature on Fraction 4 Inl,  ibition of the 
Lymphocyte Cyclic AMP Response to Isoproterenol* 
Preincubation  Condition  Cyclic AMP  Inhibition  temperature 
pmols/lO  t cells  % 
37°C  Buffer  10.0 
10 mM isoproterenol  19.0 
10 mM isoproterenol -}- Fx 4  11.0  89 
0°C  Buffer  9.0 
10 mM isoproterenol  25.0 
10 mM isoproterenol -t- Fx 4  23.0  12 
* 1.5 X  106 lymphocytes in 0.5 ml buffer were preincubated at 0 or 37°C with 500 ng/ml 
fraction 4 for 90 min, after which isoproterenol was added to a final concentration of 10 mM 
and the incubation was continued for another 10 rain at 37°C. 1086  B.  PERT  CrSSIS  AND  CYCLIC  AMP 
fraction 1 at 37°C for 90 rain, washed twice, and stimulated with isoproterenol 
in the usual way. Marked inhibition was still demonstrable, indicating that the 
inhibitory effects of B. perlussis were not readily reversed. 
DISCUSSION 
The  results  of  these  studies  indicate  that  a  lnacromolecular component of 
B. perlussis cultures is able to alter cyclic AMP metabolism in human lympho- 
cytes in vitro. The major change is a reduction in the response of exposed cells 
to agents that normally raise lymphocyte cyclic AMP concentrations, including 
isoproterenol,  PGE1,  acetylcholine,  and  methacholine.  Since  the inhibition  is 
not limited to ~ adrenergic agonists, it cannot be considered to be a ~ adrenergic 
blocking effect, per se. 
In contrast, on the basis of in vivo studies pertussis has generally been classi- 
fied as a ~ adrenergic blocking agent (5, 6). However, the discrepancy may be 
more apparent than real since a careful review of data obtained in intact animals 
indicates  that  information  on  possible pertussis  effects on  responses  to  non- 
adrenergic hormones are actually very limited (5,  10). Moreover, there is ample 
evidence to indicate that pertussis and [3 adrenergic blocking agents do not pro- 
duce  identical physiological changes in vivo, although  considerable  similarity 
exists (11).  Inasmuch as extra-adrenergic effects of pertussis are demonstrable 
in vitro, exact parallelism would not be expected since 3 antagonists would have 
a more limited spectrum of action than pertussis. 
Pertussis is not the only microbial agent capable of altering cyclic AMP me- 
tabolism in mammalian cells. Endotoxins have recently been reported to poten- 
tiate the cyclic AMP  response to epinephrine in  mouse liver and spleen  (12); 
and Closlridia perfringens neuraminidase raises cyclic AMP concentrations and 
potentiates the effect of epinephrine in frog erythrocytes (13). The enterotoxic 
exotoxin of  Vibrio cholera increases cyclic AMP in intestinal mucosal cells,  the 
change developing gradually over a period of 60  90 rain (14). The alteration in 
cyclic AMP concentration appears to be a necessary event in the massive out- 
pouring of intracellular electrolytes that characterizes cholera infection.  Plant 
products  that  influence  cyclic AMP  metabolism include  concanavalin A  and 
Phaseolus  v~dgaris phytohemagglutinin  (PHA),  both  of  which  initially  raise 
cyclic AMP in human lymphocytes (9)  (C. W. Parker, manuscript in prepara- 
tion). It is interesting that with the exception of pertussis, all of the above agents 
raise cyclic AMP concentrations; however, PHA and  concanavalin A  can also 
i)roduce a fall in cyclic AMP if incubation is continued for many hours (8)  or if 
lymphocyte preparations depleted of immunoglobulin containing cells,  erythro- 
cytes, and platelets are studied. 
The basis for the altered cvclic AMP response is not clear. The development 
of inhibition with the pertussis fractions is both time and temperature depend- 
ent, as might be the case if the inactivation involved an enzymatic action at the 
plasma  membrane,  an  induced  alteration  in  protein  synthesis,  or  a  need  to CHARLES  W.  PARKER  AND  STEPHEN  I.  MORSE  1087 
transport the inhibitory factor into the cell. It is of interest that there is a delay 
in the effect of B. pertussis on cyclic AMP metabolism in vitro whereas it takes 
3-5 days to demonstrate maximal histamine sensitizing action in vivo (15). The 
delay in onset is in striking contrast to the ¢~ blocking effects of d,l-propranolol, 
which are demonstrable almost immediately, both in vivo and in vitro. Once the 
inactivation has occurred, it is not readily reversed, as indicated by the fact that 
washing  the  cells under  conditions in  which  dissociation of  the B. pertussis 
fraction from the cells is known to occur (A. Adler and S. I. Morse, unpublished 
observations) does not restore cyclic AMP responsiveness. 
Although the presence of residual pertussis products on washed cells cannot 
be excluded, the long duration of pertussis-induced lymphocytosis in vivo (ap- 
proximately 14 days) suggests that the hormonal unresponsiveness is corrected 
relatively slowly. The biochemical basis for the change in hormonal responsive- 
ness is not known. The effect is apparently not at the level of cell permeability 
to cyclic AMP since studies of cell supernatants do not reveal large amounts of 
cyclic AMP in the medium. Nor is it likely that pertussis is enzymatically in- 
activating hormonal receptors, since  simultaneous  changes  in prostaglandin, 
catecholamine, and cholinergic receptors would be required. In rat adipocytes, 
receptors for insulin and glucagon can be enzymatically degraded by trypsin 
with an associated loss of hormonal responsiveness under conditions in which 
catecholamine and other receptors are not altered (16,  17).  Conceivably, the 
inhibition could involve changes in ATP concentration or alterations in adenyl- 
ate cyclase or phosphodiesterase activity (18), either as a result of a direct action 
of pertussis or indirectly through secondary changes in protein synthesis. More 
experiments are needed to distinguish between these possibilities. 
In view of the high dilution of pertussis fraction 4 capable of producing altera- 
tions in lymphocyte cyclic AMP metabolism in vitro, it seems likely that sim- 
ilar effects occur in vivo. In support of this possibility Ortez et al. (19) have ob- 
served reduced levels of cyclic AMP and a reduced response to epinephrine in 
the spleens of pertussis-treated mice. However, pertussis is known to produce 
marked changes in lymphocyte distribution;  and the effects noted may have 
been secondary to shifts in the proportion of different cell populations in the 
spleen. Assuming that changes in lymphocyte cyclic AMP metabolism do occur 
in vivo, it is attractive to postulate that there might be a direct relationship 
between the alteration in cyclic AMP metabolism and the change in lymphocyte 
distribution.  Unfortunately, final conclusions are not yet possible. In studies 
with purified B. pertussis fractions, leukocytosis-producing activity in mice and 
the ability to inhibit PGE1 and isoproterenol stimulation in human lymphocytes 
seemed to parallel  one  another  during  purification until  the  final  Sephadex 
G-150 step, at which the recovery of cyclic AMP-inhibiting activity in fraction 
4C  fell below  the leukocytosis-producing activity. The failure to observe an 
exact parallel between the two activities could conceivably be due to the use of 
different lymphocytes for in vivo and in vitro studies or to a decreased stability 1088  B.  PERTUSSIS  AND  CYCLIC  AMP 
of the highly purified 4C fraction under the conditions chosen for the in  vitro 
incubation. 
The possibility that lymphocytosis and changes in  cyclic AMP  metabolism 
are produced  by different  macromolecules also  must be considered.  Work  in 
progress on the effect of fraction 4C on mouse and rat lymphocyte cyclic AMP 
metabolism should help to clarify this  question.  Although  it is still  uncertain 
that  the  cyclic AMP-inhibiting  activity is present  in  the  major protein  com- 
ponent of fraction 4C, it is clear that considerable purification has been achieved, 
since  marked effects on lymphocyte cyclic AMP  metabolism are obtained  at 
fraction 4 concentrations as low as 5 ng/ml. 
The  availability of a  bacterial  product  that  markedly decreases hormonal 
responsiveness  in  at  least  one cell  type may provide a  new  approach  to  the 
study of the role of cyclic AMP in complex cellular responses. Thus studies of 
the effect of pertussis on lymphocyte transformation and histamine release from 
mast cells, processes in which a modulating role for cvclic AMP has been sus- 
pected, will be of considerable  interest. 
SUMMARY 
Bordelella  perlussis  culture  fractions produce decreased metabolic responses 
to isoproterenol and epinephrine in mice and rats, suggesting the possibility of 
systemic ¢~ adrenergic blockade. The present study was undertaken to elucidate 
the mechanism of the alteration in adrenergic responsiveness and to clarify its 
relationship to other biological effects of the organism. 
Lymphocytes were selected as a suitable tissue because of the marked altera- 
tion in lymphocyte distribution in pertussis-treated mice and rats, suggesting a 
change in the surface properties of these cells. Human peripheral blood lympho- 
cytes, purified by nylon fiber chromatography, were studied. In short incubation 
experiments (20 min or less) B. perlussis did not alter the cyclic AMP response 
to  isoproterenol,  prostaglandin  E  (PGE1),  or  methacholine.  However,  when 
cells were preincubated with B. perlussis  for 90 rain at 37°C,  the responses to 
all three agents were markedly inhibited. 
Although  these  observations  provide  direct  confirmation  of  the  ability  of 
B. perlussis  to inhibit  catecholamine responsiveness, the fact that  PGEI and 
methacholine responses were also inhibited suggests that blockade at the level 
of the #  adrenergic receptor is doubtful. The inhibitory activity was localized 
in a  nondialyzable, protein-rich fraction that is precipitated from B. perfussis 
culture fluid by ammonium sulfate at 90 % of saturation. The bulk of the activity 
was obtained in the load volume after 50,000 g centrifugation in a cesium chlo- 
ride  gradient,  density  1.2-1.5  (fraction  4).  Fraction  4  produced  a  change  in 
lymphocyte hormonal responsiveness at concentrations as low as 5 ng/ml. 
The relationship between cyclic AMP inhibitory activity in isolated human 
cells and leukocytosis-producing activity in intact mice was studied.  The two 
activities seemed to parallel one another quite closely- until  the final Sephadex CHARLES W.  PARKER AND  STEPHEN I.  MORSE  1089 
G-150 fractionation step, in which the two activities were obtained in the same 
column fraction, but a greater recovery of the leukocytosis-producing activity 
was obtained. Additional purification will be required  to establish conclusively 
whether the same macromolecule is responsible for both activities. 
The availability  of a  bacterial  product  that markedly inhibits  cyclic AMP 
accumulation  in  purified  lymphocytes may help  to  clarify  the  role  of cyclic 
AMP in lymphocyte activation by antigen  and nonspecific mitogens. 
We wish to thank Miss Mary Baumann and Mrs. Mary Huber for highly capable technical 
assistance. 
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